FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.9060
-0.0221 (-2.38%)
Oct 30, 2026, 1:17 PM EDT - Market open
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $6.3 million as of October 30, 2026. It is the 43,693rd most valuable company in the world and the 5,825th biggest in the United States. Its market cap has decreased by 61.26% in one year.
Market Cap
6.30M
Enterprise Value
4.25M
1-Year Change
-61.26%
Global Rank
Country Rank
#5,825 United States
Category
ChartMarket Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $6.30M, a decrease of -99.33%. That is a compound annual growth rate of -83.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 6.30M | -57.87% |
| Dec 31, 2025 | 14.96M | -78.68% |
| Dec 31, 2024 | 70.17M | -92.58% |
| Jan 31, 2024 | 945.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Exicure | 6.87M |
| CNS Pharmaceuticals | 6.85M |
| Aprea Therapeutics | 6.59M |
| Lexaria Bioscience | 6.55M |
| Enveric Biosciences | 6.49M |
| Skye Bioscience | 6.42M |
| Senti Biosciences Holdings | 6.42M |
| XTL Biopharmaceuticals | 6.34M |